AIGEN INVESTMENT MANAGEMENT, LP - IRONWOOD PHARMACEUTICALS INC ownership

IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 218 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.17 and the average weighting 0.2%.

Quarter-by-quarter ownership
AIGEN INVESTMENT MANAGEMENT, LP ownership history of IRONWOOD PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$129,398
-61.4%
13,437
-57.9%
0.02%
-47.8%
Q1 2023$335,514
-34.1%
31,893
-22.4%
0.05%
-36.1%
Q4 2022$509,068
+224.2%
41,087
+205.3%
0.07%
+620.0%
Q4 2021$157,000
-25.9%
13,458
-34.6%
0.01%
-63.0%
Q2 2020$212,000
-69.3%
20,581
-69.9%
0.03%
-70.7%
Q1 2020$690,000
-38.8%
68,418
-19.2%
0.09%
-50.8%
Q4 2019$1,128,00084,7260.19%
Other shareholders
IRONWOOD PHARMACEUTICALS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Sarissa Capital Management LP 16,390,000$157,835,70021.26%
AlphaCentric Advisors LLC 292,500$2,816,7751.60%
Quantedge Capital Pte Ltd 179,900$1,732,4370.94%
Intrinsic Value Partners, LLC 50,355$484,9190.62%
Brown Capital Management 3,719,796$35,821,6350.55%
ARMISTICE CAPITAL, LLC 3,456,000$33,281,2800.51%
SummerHaven Investment Management, LLC 67,765$652,5770.48%
BRAIDWELL LP 1,348,099$12,982,1930.41%
AFFINITY INVESTMENT ADVISORS, LLC 50,733$488,5590.32%
EMC Capital Management 43,315$4170.31%
View complete list of IRONWOOD PHARMACEUTICALS INC shareholders